Working… Menu

Registry Study for Radiation Therapy Outcomes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01255748
Recruitment Status : Recruiting
First Posted : December 7, 2010
Last Update Posted : November 1, 2021
Information provided by (Responsible Party):
Proton Collaborative Group

Brief Summary:
The purpose of this research study is to collect and analyze information from patients being treated with various forms of radiation therapy.

Condition or disease Intervention/treatment
Solid Tumors Radiation: Proton Therapy, Photon Therapy, SRS, Brachytherapy

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 40000 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 30 Years
Official Title: Evaluation Tracking Project: A Prospective Chart Review of Patients Treated With Radiation Therapy
Study Start Date : June 2009
Estimated Primary Completion Date : June 2039

Group/Cohort Intervention/treatment
Treatment with Radiation Therapy
Includes 16 different arms to capture patient data by disease site
Radiation: Proton Therapy, Photon Therapy, SRS, Brachytherapy
Outcomes Tracking

Primary Outcome Measures :
  1. Define outcomes for patients treated at participating institutions [ Time Frame: PRN ]

Secondary Outcome Measures :
  1. Determine strategies necessary to improve patients outcome and decrease toxicities related to treatments and procedures [ Time Frame: Annually PRN ]
  2. Improve patient care by an adequate understanding of the results and patient population at participating institutions [ Time Frame: Reviewed Annually PRN ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Radiation Oncology patients

Inclusion Criteria:

  • Planned treatment with radiation therapy
  • Ability to understand and sign IRB approved consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01255748

Layout table for location contacts
Contact: Matthew Morocco 630-836-8670

Layout table for location information
United States, Alabama
Proton International at University of Alabama at Birmingham Recruiting
Birmingham, Alabama, United States, 35233
Contact: Ashley Anderson, MSN, CRNP    205-975-2880   
Principal Investigator: Adam Kole, MD         
United States, Arizona
Mayo Clinic Recruiting
Scottsdale, Arizona, United States, 85259-5499
Contact: Clinical Trials Office - All Mayo Clinic Locations    855-776-0015 (toll free)      
United States, California
California Protons Cancer Therapy Center Recruiting
San Diego, California, United States, 92121
Contact: Alexandra Crawford, MPH    858-549-7431   
Principal Investigator: James Urbanic, MD         
United States, Florida
Miami Cancer Institute Recruiting
Miami, Florida, United States, 33176
Contact: Alex Kudryashev    786-596-2000   
Principal Investigator: Michael Chuong, MD         
United States, Illinois
Northwestern Medicine Chicago Proton Center Recruiting
Warrenville, Illinois, United States, 60555
Contact: Don Smith, MS, CCRC    630-933-7820   
Principal Investigator: William Hartsell, MD         
United States, Louisiana
Willis-Knighton Cancer and Proton Therapy Center Recruiting
Shreveport, Louisiana, United States, 71103
Contact: Briana Barrow, CCRC    318-212-8671   
Principal Investigator: Lane Rosen, MD         
United States, Maryland
Maryland Proton Treatment Center Recruiting
Baltimore, Maryland, United States, 21201
Contact: Caitlin Eggleston    410-328-7586   
Principal Investigator: Elizabeth Nichols, MD         
United States, New Jersey
ProCure Proton Therapy Center Recruiting
Somerset, New Jersey, United States, 08873
Contact: Heba Darwish    732-357-2676   
Principal Investigator: Henry Tsai, MD         
United States, New York
New York Proton Center Recruiting
New York, New York, United States, 10035
Contact: Sidra Saeed, MS, ACRP-PM    212-994-9817   
Principal Investigator: Charles Simone, MD, FACRO         
United States, Oklahoma
Oklahoma Proton Center Recruiting
Oklahoma City, Oklahoma, United States, 73142
Contact: Jenny Washington, BSRT(T), CMD    405-773-6700   
Principal Investigator: John Chang, MD         
United States, Virginia
Inova Schar Cancer Institute Recruiting
Fairfax, Virginia, United States, 22031
Contact: Sangeetha Moturi    571-472-0343   
Principal Investigator: Gopal Bajaj, MD         
Hampton University Proton Therapy Institute Recruiting
Hampton, Virginia, United States, 23666
Contact: Donna Sternberg, RN, BSN, OCN    757-251-6839   
Principal Investigator: Christopher Sinesi, MD         
United States, Washington
University of Washington Recruiting
Seattle, Washington, United States, 98195-6043
Contact: Izzy Isaac, CCRP    206-598-5136   
Principal Investigator: Jing Zeng, MD         
Sponsors and Collaborators
Proton Collaborative Group
Layout table for investigator information
Study Chair: Carlos Vargas, MD Proton Collaborative Group
Additional Information:
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Proton Collaborative Group Identifier: NCT01255748    
Other Study ID Numbers: REG001-09
First Posted: December 7, 2010    Key Record Dates
Last Update Posted: November 1, 2021
Last Verified: October 2021
Keywords provided by Proton Collaborative Group:
cancer, proton, radiation